Eir Pharmaceuticals, LLC
Andrew Skaff has a diverse work experience that spans over several years. Andrew started their career as a Post Doctoral Research Associate at the University of Missouri-Kansas City in February 2007 and held this role until December 2016. In 2018, Andrew co-founded Eir Pharmaceuticals, LLC, where they served as the Chief Executive Officer and Chief Science Officer/Chief Operations Officer until April 2021. Additionally, they played a role as a Member of the Board of Advisors at Zorilla Research, LLC from April 2018 onwards.
Andrew Skaff completed their PhD in Biochemistry at Iowa State University from 2000 to 2006.
This person is not in any teams
This person is not in any offices
Eir Pharmaceuticals, LLC
EIR Pharmaceuticals is a biotechnology company that focuses on developing and commercializing health, wellness and pharmaceutical products for humans and animals.Its unique approach uses an intense science-based vetting system and a business-minded, scientific philosophy in pursuing products that are both commercially viable and provide asignificant health benefit. The company's team has a strong history in drug discovery, drug development, regulatory affairs, and commercialization, making us well-suited to take products from concept to the marketplace.